Author: lutZ-Weber21

SAN JOSE, Calif. and STUTTGART, Germany, Jan. 24, 2022 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused […]

Great news for researchers like us that are working on drug candidates to treat SARS-CoV-2 infections. Pfizer could demonstrate that […]

While vaccination has proven to be an effective strategy to prevent Covid-19, the need exists for inexpensive, room-temperature stable, and […]